The extracellular calcium-sensing receptor (CaSR) located in either luminal or basolateral cell membranes of various types of renal tubules including proximal tubules, Henle's loop and collecting ducts has been thought to play a fundamental role in electrolyte metabolism. To further identify the physiological roles of the CaSR, we examined the effects of Ca 2+ and calcimimetics neomycin (Neo), gentamicin and gadolinium chloride (Gd 3+ ) on the intracellular pH (pHi) of in vitro microperfused mouse medullary thick ascending limb (mTAL) cells of Henle's loop, by loading the cells with fluorescent pH indicator 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein and measuring the ratio of fluorescence emission at 530 nm after exciting the dye at 490 and 440 nm. In a steady-state condition in Hepes-buffered solution, the pHi in the mTALs was 7.29 ± 0.04 (n = 9). A concentration of 200 μ mol/l Neo in the basolateral side decreased the pHi after 1 min by −0.13 ± 0.02 (n = 34, p < 0.0001). The other calcimimetics showed similar effects on pHi, whereas none of these calcimimetics in the lumen affected pHi. Na + removal or the inhibition of Na + and proton transport with amiloride, bumetanide, or bafilomycin did not eliminate the effect of Neo on pHi. On the other hand, Cl − removal clearly eliminated the Neo-induced pHi decrease (−0.06 ± 0.01 vs −0.00 ± 0.05 in Cl − removal, n = 4, p < 0.003). Thus, we have demonstrated for the first time that the CaSR is involved in the regulation of the pHi in the mTAL and requires Cl − to exert its effect. intracellular pH; renal medulla; chloride; amiloride; BCECF
vasopressin-stimulated NaCl reabsorption in mouse TALs (Desfleurs et al. 1998) . Accordingly, hypercalcemia is thought to cause polyuria due to activation of the CaSR and subsequent inhibition of tubular NaCl and water reabsorption in the TALs and CDs.
Thus far, contribution of the CaSR in the homeostasis of acid-base balance has not often been discussed in the kidneys. While numerous studies were conducted to elucidate the roles and mechanisms of the CaSR-mediated phenomena, little is known about the relationship between acid-base metabolism and the CaSR in kidneys. It has been shown that the CaSR is expressed along the entire gastrointestinal tract . The activation of the CaSR is known to play an important role in gastric acid secretion (Geibel et al. 2001) . It is well known that pH has a strong physical relationship to the ionic activity of Ca 2+ . The ionic activity of Ca 2+ in the intraand extracellular fluids plays an important role in regulating multiple biological activities of membrane transporters. Considering that the ionic activity of Ca 2+ is dependent on pH, it is of great interest to know whether the CaSR also plays a role in regulating acid-base balance in the kidneys.
In the present study, we conducted a series of experiments examining the effects of activation of the CaSR on the intracellular pH of the mTAL, in which dynamic transepithelial NaCl reabsorption takes place.
METHODS AND MATERIALS
C57BL/6 mice were obtained from Japan SLC, Inc. (Hamamatsu). The mice were anesthetized with 50 mg/ kg of intraperitoneal pentobarbital and the left kidneys were removed. The mTALs were microdissected with fine forceps under a stereoscopic microscope. A fragment of the mTAL was transferred to a chamber on the stage of an inverted microscope (IX-71, Olympus Co. Ltd., Tokyo) and was microperfused in vitro using Burg's method (Burg et al. 1966) , with some modifications as previously described (Kondo and Fromter 1987) . Our system allowed the complete exchange of either luminal or basolateral solution in one second. The microdissection dish contained a medium of 135 NaCl, 3.0 KCl, 2.0 KH 2 PO 4 , 1.5 CaCl 2 , 1.0 MgCl 2 , 10 Hepes, 5.5 glucose,
The extracellular calcium-sensing receptor (CaSR) belongs to Family C of the superfamily of G protein-coupled receptors (GPR), which is activated by extracellular Ca 2+ . The CaSR was first cloned and characterized in bovine parathyroid chief cells by Brown et al. (1993) . In parathyroid glands, the CaSR activates phospholipase C (PLC), resulting in the inhibition of parathyroid hormone (PTH) secretion . The CaSR is also expressed in multiple tissues including C cells in the thyroid (Garrett et al. 1995) , renal tubules, gastric mucous epithelial cells (Rutten et al. 1999) , ileum (Ruat et al. 1995) , bone, bone marrow cells (House et al. 1997) , pituitary (Ruat et al. 1995) , nerve terminals in brain (Ruat et al. 1995) , keratinocytes in skin (Bikle et al. 1996) , islet B-cells in pancreas (Bruce et al. 1999) , lung (Ruat et al. 1995) , and heart .
The kidneys play a crucial role in the regulation of calcium metabolism in mammals. The mechanism of calcium handling in the kidneys has been investigated by many researchers (Seldin 1999; Unwin et al. 2004) . The renal tubules such as the proximal tubules (PTs), the thick ascending limbs (TALs) of Henle's loop, and the distal tubules (DTs) are mainly involved in reabsorbing the filtered calcium, and their functions are mainly controlled by PTH and vitamin D (Unwin et al. 2004) . Parathyroid hormone is known to control renal tubular functions such as phosphate reabsorption in the proximal tubules and cyclic adenosine monophosphate (AMP) production in the TALs.
In kidneys, it has been clearly demonstrated that the CaSR is located in multiple renal tubule segments including PTs, TALs, and collecting ducts (CDs) (Ba and Friedman 2004; Hebert 2004) . Stimulation of the CaSR in rat kidneys has been shown to inhibit vasopressin-activated adenosine 3′,5′-cyclic monophosphate accumulation in the medullary TALs (mTALs) of Henle's loop and the CDs, leading to inhibition of NaCl reabsorption and water reabsorption, respectively (Chattopadhyay et al. 1996) . It is also known that activation of the CaSR has been shown to inhibit Ca 2+ reabsorption without affecting basal and and 5.0 l-alanine in mmol/l, titrated to pH 7.4 with NaOH. Both sides of the mTAL were microperfused with the same solution used for microdissection. Two μ l of 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) as the acetoxymethyl ester (BCECF/AM) at 1 mmol/l in dimethylsulfoxide (DMSO) was diluted into 2 ml of the above solution. This solution was then loaded into the mTAL by exchanging the basolateral solution while the perfusion of the chamber was stopped.
After the incubation at room temperature for 30 min, the dye in the chamber was washed out thoroughly with the control solution. The tubule was then incubated at 38˚C for 30 min and the BCECF trapped in the cytosol of the mTAL cells was then excited by a xenon lamp at 490 and 440 nm wavelengths. Then the ratio of emission at 530 nm was converted to pHi by the Aquacosmos system (Hamamatsu Photonics Co. Ltd., Hamamatsu). Emission lights in the visualized images were analyzed after the background emission was subtracted. For the calibration of the dye in the mTAL cells, both luminal and basolateral cell membranes of the mTALs were permeabilized to H + and K + with 7 μ mol/l nigericin. The pH in the ambient solutions was changed by titrating the calibration solutions. Calibration solutions contained in mmol/l 20 NaCl, 118 KCl, 2.0 KH 2 PO 4 , 1.5 CaCl 2 , 1.0 MgCl 2 , 10 Hepes, 5.5 glucose, and 5.0 l-alanine and were titrated to the intended pH with NaOH or HCl.
BCECF/AM was purchased from Molecular Probes, Inc. (Eugene, OR, USA). Neomycin (Neo), gentamicin (Gen), gadolinium chloride (Gd 3+ ), and bafilomycin were purchased from Sigma Chemical Co. (St. Louis, MO, USA). All the other chemicals were reagent grade and purchased from Wako Pure Chemicals (Osaka).
Data were expressed as mean ± S.E. Statistical analyses were performed with Student's paired t-test.
All experiments were performed in compliance with the relevant institutional guidelines in Tohoku University Graduate School of Medicine.
RESULTS

Calibration of BCECF in the mTALs
To calibrate BCECF in the mTAL cells, both the luminal and basolateral cell membranes were permeabilized to K + and H + by nigericin under high K + condition as described in "Methods and Materials". The representative trace of the excitation ratio (REX490/440) is shown in Fig. 1 . Fig. 2 depicts the averaged excitation ratios (REX490/440) at ambient pHs of 6.9, 7.4, and 7.9 in the mTAL cells. These results clearly show that BCECF is applicable to the measurement of intracellular pH (pHi) in the mTALs of mouse kidneys.
Using this method, the pHi of the mTALs was 7.29 ± 0.04 (n = 9) when microperfused in vitro in a basal condition. First, the mTAL segment was microperfused in vitro in Hepes-buffered normal solution in both luminal and basolateral sides. To calibrate the BCECF in the mTAL cells, REX490/440 upon various pHs was applied to the mTAL cells by permeabilizing the cell membrane to K + and H + with 7 μ mol/l nigericin on both sides of the mTAL and the ambient K + was equilibrated to the cytosol by increasing the ambient K + to 135 mmol/l. Stepwise changes of the ambient pH between 6.9 and 7.9 caused the prompt changes of REX490/440, indicating that BCECF in the mTAL cells is a good indicator of pHi in mouse mTAL cells.
The effects on pHi of calcimimetics in luminal and basolateral solutions
To examine whether the CaSR is involved in the regulation of pHi in the mTALs, the effects of calcimimetics such as Neo, Gen, Gd 3+ , and Ca 2+ on pHi were observed. None of the calcimimetics and Ca 2+ added to the lumen either acidified or alkalinized the mTAL cells, as shown in Fig. 3 . The same calcimimetics and Ca 2+ applied to the basolateral solution all caused significant intracellular acidification of the mTALs (Fig. 4 and Table 1 ).
The effects of luminal bumetanide on Neoinduced intracellular acidification in the mTALs
To identify whether the CaSR-induced intracellular acidification is exerted by affecting the bumetanide-sensitive Na + -K + -2Cl − cotransporter (NKCC2) in the luminal membrane of the mTALs, the effect of 200 μ mol/l Neo on pHi was observed in the presence of 100 μ mol/l bumetanide in the lumen. Bumetanide added to the lumen of the mTALs did not affect pHi; this is shown as a representative trace in Fig. 5 . Neoinduced intracellular acidification in a minute was changed from −0.26 ± 0.07 to −0.30 ± 0.01 in the presence of luminal bumetanide (n = 4, N.S. vs control), indicating that the effect of Neo on pHi is not the phenomenon related to the inhibition of NaCl reabsorption via the NKCC2.
The effects of amiloride on Neo-induced intracellular acidification in the mTALs
To identify whether the calcimimeticsinduced intracellular acidification is exerted by the inhibition of amiloride-sensitive Na + /H + exchangers in the luminal or basolateral membranes of the mTALs, the effect of 200 μ mol/l Neo on pHi was observed in the presence of 1mmol/l amiloride in either lumen or the bath. It has been reported that 1 mmol/l amiloride inhibits (Tse et al. 1993) . One mmol/l amiloride added to the lumen of the mTAL acidified the mTAL cells by 0.03 ± 0.01 (n = 5) in 2 min, whereas the same concentration of amiloride in the bath caused pHi decrease by 0.32 ± 0.02 (n = 3) in 2 min. As shown in Fig. 6 , the acidifying effect of Neo was not blocked by either luminal (Panel a) or basolateral (Panel b) amiloride, indicating that the effect of the CaSR activation does not involve inhibition of the Na + /H + exchangers.
The effect of ambient Na + removal on Neoinduced intracellular acidification in the mTALs
To examine directly whether Na + -dependent transport is involved in the CaSR-induced intracellular acidification of the mTAL cells, ambient Na + was eliminated by replacing Na + with N-methyl-D-glucamine (NMDG) in both luminal and basolateral solutions, and the effect of 200 μ mol/l Neo on pHi was examined. Removal of ambient Na + decreased pHi by 0.14 ± 0.04 (n = 3) in a steady-state condition. Changes pHi in 1 min after the addition of 200 μ mol/l Neo to the bath in the presence and absence of ambient Na + were −0.04 ± 0.01 (n = 3) and −0.06 ± 0.02 (n = 3, N.S.), respectively. These results indicate that Na + -dependent pHi-regulating mechanisms such as the Na The effect of luminal bumetanide at 100 μ mol/l on pHi decrease induced by 200 μ mol/l Neo was examined in a representative experiment. As shown in the representative trace, the pHi decrease induced by Neo was not affected by bumetanide. 
The effect of ambient Cl − removal on Neoinduced intracellular acidification in the mTALs
To examine directly whether Cl − is involved in the CaSR-dependent intracellular acidification in the mTALs, the ambient Cl − was replaced with gluconate and the effects of Neo on pHi were observed. Elimination of ambient Cl − decreased pHi by 0.07 ± 0.01 (n = 4, p < 0.01) in a steadystate condition. As shown in Fig. 7 , removal of ambient Cl − attenuated the pHi changes of the mTAL induced by 200 μ mol/l Neo from −0.06 ± 0.01 to −0.00 ± 0.05 in 1 min (n = 4, p < 0.003). These results strongly indicate that the major portion of the intracellular acidification induced by CaSR activation requires the presence of ambient Cl − .
The effects of bafilomycin on Neo-induced intracellular acidification in the mTALs
To identify whether the CaSR-induced intracellular acidification dependent on ambient Cl − is exerted by the inhibition of H + -ATPase in the mTAL, the effect of 1 μ mol/l bafilomycin on pHi decrease induced by basolateral Neo was observed. One μ mol/l bafilomycin added to the lumen side changed pHi of the mTAL cells by −0.03 ± 0.02 (n = 7, N.S. vs no change) in a steady-state condition. Neo-induced intracellular acidification in a minute was not changes by 1 μ mol/l bafilomycin in bath (−0.05 ± 0.01 vs −0.07 ± 0.01 in control, n = 7, N.S.).
DISCUSSION
In the present paper, we demonstrated for the first time that activation of the CaSR acidified the epithelial cells of mouse mTALs. We also demonstrated that the intracellular acidification is completely abolished by elimination of ambient Cl − , and that Na + transport is not involved in the process. Our data clearly show that the CaSR has an important role in the regulation of acid-base transport in the mTALs.
The role of the mTALs in NaCl and acid-base homeostasis in the kidney
Thus far, enormous studies have been conducted to elucidate the mechanism of transepithelial fluid and electrolyte transport, and their regulation in the mTALs. We know now that the most major role of the mTALs for fluid and electrolyte metabolism is the generation of NaCl gradient which favors the formation of the complex urineconcentrating mechanism. It is of great importance that the deterioration of the NaCl reabsorption in the mTALs leads to Bartter syndrome, which is an important disease with polyuria, hyponatremia, hypokalemia, and metabolic alkalosis. Surprisingly, recent report showed that the abnormal function of the CaSR due to molecular dysfunction also causes Bartter syndrome. It is also of great importance that hypercalcemia causes polyuria due to the deterioration of the urine-concentrating mechanism via the activation of CaSR in the TALs and CDs (Hebert 2004) .
NaCl reabsorption and the CaSR in the mTALs
Previous studies on the effects of activation of CaSR in the TALs have shown that the major target of the CaSR activation is NaCl reabsorption. The transporters such as NKCC2, K + channel renal outer-medullary K channel (ROMK), and Na + /K + ATPase have been thought to be inhibited by activation of the CaSR (Hebert 2004) . However, these findings have not yet been clarified enough in mouse mTALs. In the present study, we examined the effect of bumetanide on the Neo-induced intracellular acidification to determine whether our observation is a secondary phenomenon caused by the modulation of NaCl reabsorption in the mTALs. If the intracellular acidification of the mTALs via the CaSR is secondary to the modulation of NaCl reabsorption, p r e t r e a t m e n t o f t h e t u b u l a r l u m e n w i t h bumetanide would lead to the inhibition of the CaSR-induced intracellular acidification of the mTALs. As a result, our data clearly show that the intracellular acidification of the mTALs by activation of CaSR is an independent process that would be directly exerted by the CaSR activation.
Contribution of the CaSR to transepithelial Ca 2+ transport in the mTALs
There have been very few reports examining net Ca 2+ transport in the mTAL. It was reported (Suki et al. 1980 ) that the mTAL possesses passive potential-dependent net Ca 2+ reabsorption. However, it was also reported (Mandon et al. 1993 ) that the mTAL of rat kidney can reabsorb neither Mg 2+ nor Ca 2+ , whatever transepithelial voltage (Vte). Further studies are mandatory to evaluate whether the effects of the CaSR activation is related to the net Ca 2+ reabsorption in the mTALs due to the limitation of the information and arguments regarding the presence of transepithelial Ca 2+ transport in the mTALs.
Relation to H + -ATPase and Na
+ /H + exchangers in the luminal membranes of the CaSR activation in the mTALs
The presence of N-ethylmaleimide (NEM)-sensitive vacuolar H + -ATPase in the TALs has been demonstrated first in rat kidneys (Brown et al. 1988) . The H + -ATPase is selectively localized to luminal membranes and submembranous vesicles. It has also been demonstrated that the luminal membranes of the TALs possess NHE3 and another Na + /H + exchanger NHE2 in rat kidneys (Wang et al. 2001; Capasso et al. 2002) . In our experimental protocol, we examined the involvement of these Na + /H + exchangers in the luminal membranes of the mTALs by either inhibiting ambient Na + with a high dose of amiloride or eliminating ambient Na + . We could not observe any minimal effects of these maneuvers on CaSRinduced intracellular acidification. Taken together, our data suggest that luminal acid-base transport is not involved in the regulation of the pHi by the CaSR activation in the mTAL. Further studies including the measurement of transepithelial acid-base transport rate are required to elucidate this issue.
Dependence on Cl − of the calcimimetics-induced pHi decrease in the mTALs
We demonstrated in the present research that the ambient Cl − has strong relationship to the intracellular acidification due to the CaSR activation in mouse mTALs. While transepithelial Cl − transport is the major function of the mTALs, bumetanide neither affect pHi by itself nor inhibit the intracellular acidification due to the CaSR activation. These results indicate that the major transepithelial Cl − transport is not involved in the intracellular acidification due to the CaSR activation. Other possibilities including modulation of membranous Cl − -dependent acid-base transporters and luminal Cl − -sensitive H + -ATPase (Wagner et al. 2004) , and even the modulation of the intrinsic bicarbonate production in the mTAL cells should also be considered. Further studies are mandatory to elucidate the precise mechanism of the intracellular acidification due to the CaSR activation in the mTALs.
Relation to HCO 3 − transport of the CaSR activation in the mTALs
We eliminated the contribution of HCO 3 − transport by using a simple Hepes-buffered solution to examine the mechanism of the CaSR effect in the present study. Our research protocols enabled us to examine the effect of the CaSRinduced inhibition on HCO 3 − -independent acidbase transport in the mTALs. In addition to our present results, it is still attractive to hypothesize that HCO 3 − transporters such as Cl − /HCO 3 − exchanger AE2, electroneutral (NBC[N]1) and electrogenic (NBC4) Na + -HCO 3 − cotransporters in the basolateral membranes of the mTALs (Alper et al. 1997; Stuart-Tilley et al. 1998; Vorum et al. 2000; Xu et al. 2003) are involved. Affecting these transporters in the mTAL by CaSR activation might lead to either acidification or alkalinization of the mTAL cells in a CO 2 /HCO 3 − -buffered environment if the CaSR is related to these transporters. Further studies are mandatory to elucidate the entire view of the involvement of CaSR activation in acid-base transport in the mTALs.
